Literature DB >> 6802350

Immunotherapy reassessed.

C J Williams.   

Abstract

Mesh：

Year:  1982        PMID： 6802350      PMCID： PMC1496509          DOI： 10.1136/bmj.284.6320.920-a

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  14 in total

1.  Demonstration of resistance against methylcholanthrene-induced sarcomas in the primary autochthonous host.

Authors:  G KLEIN; H O SJOGREN; E KLEIN; K E HELLSTROM
Journal:  Cancer Res       Date:  1960-12       Impact factor: 12.701

2.  Immunity to methylcholanthrene-induced sarcomas.

Authors:  R T PREHN; J M MAIN
Journal:  J Natl Cancer Inst       Date:  1957-06       Impact factor: 13.506

Review 3.  The adjuvant effect of microbial products on the immune response.

Authors:  R G White
Journal:  Annu Rev Microbiol       Date:  1976       Impact factor: 15.500

4.  Back to the drawing board--the need for more realistic model systems for immunotherapy.

Authors:  P Alexander
Journal:  Cancer       Date:  1977-07       Impact factor: 6.860

5.  Lymphocyte mediated cytotoxicity in vitro. Induction and inhibition by humoral antibody and nature of effector cells.

Authors:  P Perlmann; H Perlmann; H Wigzell
Journal:  Transplant Rev       Date:  1972

Review 6.  BCG and cancer (first of two parts).

Authors:  R C Bast; B Zbar; T Borsos; H J Rapp
Journal:  N Engl J Med       Date:  1974-06-20       Impact factor: 91.245

7.  Possible role of macrophage mediated nonspecific cytotoxicity in tumour resistance.

Authors:  J B Hibbs; L H Lambert; J S Remington
Journal:  Nat New Biol       Date:  1972-01-12

Review 8.  Immunotherapy of cancer: current status.

Authors:  J E Goodnight; D L Morton
Journal:  Prog Exp Tumor Res       Date:  1980

Review 9.  Studies on the immunogical effects of BCG and its components: theoritical and therapeutic implications.

Authors:  M S Mitchell
Journal:  Biomedicine       Date:  1976
View more
  1 in total

1.  Combination chemotherapy (VAC/FMC) with immunostimulation in metastatic breast cancer: a randomized study comparing different times and routes of administration of Corynebacterium parvum.

Authors:  D Fritze; B Massner; R Becher; M Kaufmann; H J Illiger; J Hartlapp; W Queisser; U Abel; L Edler; A C Mayr
Journal:  Klin Wochenschr       Date:  1984-02-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.